INTRODUCTION
US health care suffers from its inability to provide high quality and consistent care despite massive and increasing spending. 1 The value deficit is substantial, with the Congressional Budget Office and Institute of Medicine each estimating that 30-40% of US spending is 'waste'. 2, 3 Similarly, our national health information technology (HIT) policy has been accused of costing trillions, burdening clinicians and adding risks without a clear return of increased efficiency, safety or quality. [4] [5] [6] [7] Electronic health records (EHRs) were ubiquitously promoted to deliver value by decreasing effort and errors. 5, 6, 8 Extensive EHR software was purchased and implemented at significant cost, with 75% of hospitals and 44% of primary care providers now using at least basic electronic records. 9 However, increasing evidence suggests EHR implementations alone have not delivered anticipated cost reductions or outcome improvements. 4, [10] [11] [12] [13] Also, experience with use of data through enterprise data warehouses (EDW) and analytics is limited. As of 2014, the benefit of HIT remains controversial. 9, 14 This discussion first explores 'value' in the context of our major national IT investment, and then proposes three recommendations to improve HIT's return on investment. Recommendations focus on known areas of weakness and confusion: HIT usability, interoperability, and quality. For each, we offer a summary of the current approach, reasons the approach has and will remain inadequate, and recommendations for policy course corrections.
2014 is a time when course corrections are possible. Office of National Coordinator (ONC) leadership transition, specification of Meaningful Use (MU) Stage III, congressional engagement, and proposed shortened regulatory cycles 15 all reflect an opportunity. We suggest course corrections are needed now that tie our substantial HIT investment to enhanced national value to benefit the economy, to reduce healthcare costs, and to improve clinical efficiency and care quality.
UNDERSTANDING VALUE IN THE CONTEXT OF A NATIONAL INVESTMENT
Before proposing policy recommendations, there should be alignment between goals and our national investment. Early in the last decade, the USA responded to an alarming report by the Institute of Medicine that medical errors represented a serious public threat. 8 National efforts were undertaken, including creation of the ONC for Health IT. 16 The healthcare industry rallied in response, highlighting safety and error reduction as critical needs requiring technology solutions such as the EHR.
Fifteen years later, the landscape has changed. Payment models are shifting toward risk-sharing and value-based healthcare. Measurement of risk and quality are critical to national health reform. Studies and pilots over the last decade reveal that cost reduction and quality improvement require far more than safety and error reduction. The most successful quality improvement efforts have incorporated clinical data to: (1) benchmark outcomes to detect inconsistency and to align care with best practices, 17, 18 (2) identify high-risk patients and augment resources before expensive catastrophes, 19, 20 and (3) support population-based analytics and preventive care. 21, 22 As experts increasingly used and benefited from clinical data, 
RECOMMENDATION: REQUIRE CLINICAL SOFTWARE USABILITY OVER FUNCTIONALITY
Usability of HIT is the learnability, efficiency and satisfaction with which users achieve a specific set of tasks in a particular environment. 23 Usability is required for HIT to be effective and is foundational to deriving benefit from software. 24, 25 HIT usability is widely acknowledged as poor, generating frustration, medical errors, and inefficiencies. 9, 15, [26] [27] [28] Failure to integrate smoothly with clinical workflow severely exacerbates the lack of usability and, at times, lack of usefulness of the technology. [29] [30] [31] [32] Just as a perceived lack of usefulness hinders HIT adoption, 33 ,34 a lack of EHR usability undermines patient care, accurate documentation and functional clinical decision support (CDS). A Healthcare Information and Management Systems Society (HIMSS) task force states that poor usability is "possibly the most important factor hindering widespread adoption of EMRs". 23 Documentation and order entry time may increase by up to 300% after EHR implementation, 35 and medication errors may increase with computerized physician order entry. 30, 36 CDS designed to help clinicians adhere to standards of care is supposed to improve quality of care, [37] [38] [39] but functionality proves cumbersome and often ineffective. With extremely high documented override rates, 40, 41 poor CDS usability undermines its utility and one of the underpinnings of all HIT. Usability for analytics is even less often discussed than usability of the EHR itself, but is at least as important to achieve care consistency and risk reduction. 42, 43 Because so much workflow occurs outside of the EHR, EDWs-holding data from one or many institutions-combined with analytic systems, offer additional and largely untapped potential for care improvement with little focus on usable systems that offer an effective workflow to improve clinical, operational, and financial efficiency.
Recommendation for usability
Address poorly designed and user-unfriendly software, proliferated through rushed national mandates that limit HIT's benefits. MU Stage III should reduce requirements on EHR functionality and instead focus on defining and requiring effective usability for both EHR and analytics systems.
RECOMMENDATION: MANDATE ROBUST INTEROPERABILITY
To use data, a system must have access to the data. Yet, our national health infrastructure created islands, not highways.
Today, data are held in many silos, including laboratory systems, pharmacy, revenue cycle software, EHRs, EDWs, and other independent systems. While interoperability is widely acknowledged as essential, 31 there is increasing understanding that it is seldom achieved 44 and failure will undermine national goals. [45] [46] [47] Why is this information not shared between clinical systems that received heavy national subsidization and the systems that offer analytics capabilities? Despite successful sharing in other industries and several data standards in healthcare, the general argument is that data sharing within known formats is too hard. An immediate challenge is assuring information is available for transitions in care. Planned policy changes require sharing of patient summaries within a consolidated clinical document architecture format to address this need. 48 But, while sharing summaries addresses a decade-old goal to reduce errors when a patient moves from one healthcare organization to another, it fails to actually improve the practice of care. A patient summary is simply not adequate to perform the clinical analytics that can reduce costs and improve outcomes. Consider a patient summary describing a patient as hypertensive, diabetic, and on two medications. Now consider the full clinical record, which incorporates information on social situation, course of care, medication compliance, recent complications, vital signs, and laboratory values. A summary alone simply does not have enough information to measure quality, understand risk, empower population health management, or support benchmarking. The nation subsidized and gave incentive to healthcare organizations to implement EHRs and to doctors to capture the data, but we have allowed lock-in of the precious data in which we invested. Locking in data stifles innovation in healthcare and severely reduces our chance of meeting national goals.
Recommendation for interoperability
Current policy requires sharing patient summaries, but not full clinical content to empower analytics. MU Stage III must require sharing full clinical data in a common format among EHRs, EDWs, and analytics systems. Only with this change can we empower clinical analytics and quality workflow to deliver on HIT's promised value.
RECOMMENDATION: IMPLEMENT A REFINED APPROACH TO QUALITY
Though the HITECH Act of 2009 authorized billions of dollars to support a pathway to meaningful use of data, 49 the effects of this national approach to quality measurement remain unclear. 50, 51 While there is broad agreement that quality is important, national discussions seldom focus on what is actually measured and how those measurements are used.
Early efforts in quality measurement, such as those from the National Surgical Quality Improvement Program, were focused exclusively on aligning care with national guidelines proven to improve outcome. This was effective in improving care and reducing costs. 52, 53 As clinical quality measure (CQM) efforts were expanded, the program changed. Quality measures became centrally defined and standards bodies came to serve two masters: national care guidelines, and 'feasibility.' Industry and healthcare organizations found newly imposed measures difficult, and the government worked to be responsive. The change in practice was to no longer solely align measures with what improved care, but to also focus on feasibility-how easy it was to input and extract the data. 54 It is not possible to serve two masters equally. Either quality measures align with what is proven to advance national goals or they align with what is easiest for vendors and busy clinicians. Thus, new measures focus heavily on discrete data elements-for example, hemoglobin A1c values rather than poorly controlled diabetes, or process measures such as smoking cessation counseling rather than tobacco use. An example highlights the challenge: Although lowering smoking rates is tied to reduced costs, the government has chosen the 'feasible' CQM of smoking cessation counseling. A healthcare organization (HCO) wishing to address this measure has added a line to every discharge summary recommending the patient quit smoking. To avoid missing patients, this is added to all discharge summaries of smokers and non-smokers, buried within pages of text. The result is excellent calculated quality scores, but little or no proven influence on outcomes or cost. The risk, well described by Goodhart's law, is that the measures become a target in themselves rather than a road toward national goals. 55 When the targets (measures) are so distant from the goals (reduced costs and improved outcomes), is it really a surprise that goals are not met?
In fact, the problem is even worse. Quality measures were initially piloted within motivated institutions, where clinicians worked hard to assign accurately the correct patients to the correct measures. Now, CQMs are being reported by less motivated hospitals and staff, struggling under constrained resources to meet minimal national reporting requirements. If there were a requirement that measurement needed to be accurate, this would be part of the healthcare organization focus. But there is currently no requirement for accuracy; payment is for the report, whether right or not. Are we surprised current quality measurement is shown repeatedly to be wrong? [56] [57] [58] The foundation of national efforts to improve quality is both inaccurate and incomplete.
Recommendations for quality Current quality measures focus on convenience and on process rather than on clinical outcomes; they lack incentive for accurate capture. Instead, we urge that: (1) measures should be aligned with national care guidelines rather than feasibility, targeting what is meaningful rather than what is easy to hit; (2) MU Stage III should include meaningful requirements on accurate measure collection. It will not matter how successful we are at reporting and improving quality measures if the underlying information infrastructure is misdirected (table 1) .
CONCLUSION
Healthcare's inefficiency and mixed quality contrast starkly with national goals of increasing value from HIT. If we are to meet national goals of improving outcomes and reducing costs, our intermediate markers must align with those goals. Aiming toward unproven intermediate markers-such as level of EHR adoption, sharing of a small subset of patient data, and unproven and inaccurate quality measures-places our heavy HIT investment at risk of failure.
Significant use of analytics is an essential step. Many analytics software vendors have transitioned from exclusive use of We also recognize that health care is a complex system and that technology is only part of the solution. We present technology solutions to address weakness in technology policy. Other factors outside the scope of this paper, especially workflow, health IT safety, and implementation processes, are equally critical to achieving clinical goals, improving patient experience, and maintaining public trust.
The national health IT infrastructure investment is staggering, but small compared to the prize of addressing our healthcare woes. In the complex healthcare system, results will not be instantaneous or guaranteed, but progress must be closely watched and measured. Attaining the ambitious and noble goals of improving outcomes and reducing costs in health care will meaningfully influence our economy and national wellbeing. As a nation, we have already spent hundreds of billions of dollars on HIT. 59, 60 With reasoned and moderate course corrections, our health IT investment will be far more likely to deliver its promised benefits to our population and economy. 
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